Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for vascular function in obese individuals at high risk of diabetes
2009-013100-32Phase 2Completed
- Sponsor
- University of Exeter
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vildagliptin in obesity and prediabetes, sponsored by University of Exeter. Primary endpoint: Capillary pressure. Started Nov 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
obesityprediabetes
Beyond the preview
Go deeper on 2009-013100-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013100-32.